Category: 925006-96-8

Reference of 925006-96-8, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Article, and a compound is mentioned, 925006-96-8, Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate, introducing its new discovery.

Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation

Antiplatelet drugs are promising therapeutics to intervene with platelet aggregation in arterial thrombosis, most prominently in myocardial infarction and ischemic stroke. Here, we describe the synthesis and structure-activity relationships of potent inhibitors of platelet aggregation based on the 1,5-diarylpyrazol-3-carboxamide scaffold. Analogs from this series demonstrated potent anti-aggregatory activities against arachidonic acid-induced platelet aggregation, as measured by turbidimetric method of Born. 1,5-Diarylpyrazole-3- carboxamides obtained with small-basic amines (7, 8, 50, 51, 61, 62) displayed the strongest activity with IC50 values in low nanomolar range (5.7-83 nM). On the basis of their high potency in cellular environment, these straightforward pyrazole derivatives may possess potential in the design of more potent compounds for intervention with cardiovascular diseases.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Reference of 925006-96-8. In my other articles, you can also check out more blogs about 925006-96-8

Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Electric Literature of 925006-96-8, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 925006-96-8, Name is Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate, molecular formula is C13H13NO4. In a Article£¬once mentioned of 925006-96-8

Synthesis of ethyl isoxazole-3-carboxylates using an ionic liquid as a soluble support

A regioselective 1,3-dipolar cycloadditions of ionic liquid-supported vinyl ethers, derived from ionic liquid-supported alpha-phenylselenomethyl ether, with ethyl cyanoformate N-oxide gave supported isoxazoline derivatives, which were then cleaved from the ionic liquid support under mild acidic conditions to afford ethyl isoxazole-3-carboxylates. This new synthetic method is simple and efficient and the products are obtained in good yields.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Electric Literature of 925006-96-8. In my other articles, you can also check out more blogs about 925006-96-8

Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

In heterogeneous catalysis, the catalyst is in a different phase from the reactants. COA of Formula: C13H13NO4, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 925006-96-8, name is Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate. In an article£¬Which mentioned a new discovery about 925006-96-8

Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer’s Disease

A novel series of hybrid arylisoxazole-chromenone carboxamides were designed, synthesized, and evaluated for their cholinesterase (ChE) inhibitory activity based on the modified Ellman’s method. Among synthesized compounds, 5-(3-nitrophenyl)-N-{4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]phenyl}-1,2-oxazole-3-carboxamide depicted the most acetylcholinesterase (AChE) inhibitory activity (IC50=1.23 mum) and 5-(3-chlorophenyl)-N-{4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]phenyl}-1,2-oxazole-3-carboxamide was found to be the most potent butyrylcholinesterase (BChE) inhibitor (IC50=9.71 mum). 5-(3-Nitrophenyl)-N-{4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]phenyl}-1,2-oxazole-3-carboxamide was further investigated for its BACE1 inhibitory activity as well as neuroprotectivity and metal chelating ability as important factors involved in onset and progress of Alzheimer’s disease. It could inhibit BACE1 by 48.46 % at 50 mum. It also showed 6.4 % protection at 25 mum and satisfactory chelating ability toward Zn2+, Fe2+, and Cu2+ ions. Docking studies of 5-(3-nitrophenyl)-N-{4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]phenyl}-1,2-oxazole-3-carboxamide and 5-(3-chlorophenyl)-N-{4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]phenyl}-1,2-oxazole-3-carboxamide confirmed desired interactions with those amino acid residues of the AChE and BChE, respectively.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 925006-96-8, help many people in the next few years.COA of Formula: C13H13NO4

Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

925006-96-8, In an article, published in an article,authors is Calkan, Burcu, once mentioned the application of 925006-96-8, Name is Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate,molecular formula is C13H13NO4, is a conventional compound. this article was the specific content is as follows.

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents

In our endeavour towards the development of effective anticancer therapeutics, a novel series of isoxazole-piperazine hybrids were synthesized and evaluated for their cytotoxic activities against human liver (Huh7 and Mahlavu) and breast (MCF-7) cancer cell lines. Within series, compounds 5l-o showed the most potent cytotoxicity on all cell lines with IC50 values in the range of 0.3?3.7 muM. To explore the mechanistic aspects fundamental to the observed activity, further biological studies with 5m and 5o in liver cancer cells were carried out. We have demonstrated that 5m and 5o induce oxidative stress in PTEN adequate Huh7 and PTEN deficient Mahlavu human liver cancer cells leading to apoptosis and cell cycle arrest at different phases. Further analysis of the proteins involved in apoptosis and cell cycle revealed that 5m and 5o caused an inhibition of cell survival pathway through Akt hyperphosphorylation and apoptosis and cell cycle arrest through p53 protein activation.

If you are interested in 925006-96-8, you can contact me at any time and look forward to more communication. 925006-96-8

Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.925006-96-8,Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate,as a common compound, the synthetic route is as follows.

General procedure: The ethyl ester intermediate 15 (2mmol) was dissolved in 98 ethanol/120 water (3:1, 10mL), and 19 NaBH4 (0.38g, 10mmol) was added. The reaction mixture was sealed with a balloon and stirred overnight at room temperature. Upon the completion of reduction, the solution was partitioned between EtOAc (40mL) and 1N HCl (25mL). The organic layer was washed with saturated NaHCO3 and brine, dried over Na2SO4, concentrated in a rotovapor. The alcohol was used directly for next step without purification., 925006-96-8

The synthetic route of 925006-96-8 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Bi, Fangchao; Song, Di; Zhang, Nan; Liu, Zhiyang; Gu, Xinjie; Hu, Chaoyu; Cai, Xiaokang; Venter, Henrietta; Ma, Shutao; European Journal of Medicinal Chemistry; vol. 159; (2018); p. 90 – 103;,
Isoxazole – Wikipedia
Isoxazole | C3H3NO – PubChem

925006-96-8,925006-96-8, Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate is a Isoxazoles compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

General procedure: To a solution of CH3CN (0.43mL, 7.32mmol) in anhydrous THF (10mL) was added 1.6M methyl lithium in diethyl ether (2.30mL, 3.66mmol) at-78C under nitrogen. The mixture was stirred at-78C for 0.5h, and ethyl 5-(4-(tert-butyl)phenyl)isoxazole-3-carboxylate 3a (500mg, 1.83mmol) in THF (10mL) was then added dropwise. The solution was stirred at-78C for 1h and then quenched with acetic acid (0.21mL, 3.66mmol). The mixture was warmed to 0C and poured onto ice/ water (10mL) and extracted with ethyl acetate (20mL). The organic lay was dried over Na2SO4, filtered and concentrated under reduced pressure. The crude residue 4a (330mg, 75%) was obtained as a white solid and directly used for next step without further purification.

As the paragraph descriping shows that 925006-96-8 is playing an increasingly important role.

Reference£º
Article; Ye, Na; Zhu, Yingmin; Liu, Zhiqing; Mei, Fang C.; Chen, Haiying; Wang, Pingyuan; Cheng, Xiaodong; Zhou, Jia; European Journal of Medicinal Chemistry; vol. 134; (2017); p. 62 – 71;,
Isoxazole – Wikipedia
Isoxazole | C3H3NO – PubChem